Chembio's POC Lyme Disease Assay Has Specificity Similar To Lab Tests
This article was originally published in The Gray Sheet
Executive Summary
Clinical studies of Chembio Diagnostic Systems' PreVue B. burgdorferi antibody detection assay showed a specificity for the rapid point-of-care test similar to that for currently available laboratory diagnostics for Lyme disease.